|Bid||44.61 x 1000|
|Ask||47.70 x 900|
|Day's Range||43.79 - 44.80|
|52 Week Range||34.50 - 47.43|
|Beta (5Y Monthly)||1.14|
|PE Ratio (TTM)||21.37|
|Earnings Date||Apr 12, 2020 - Apr 16, 2020|
|Forward Dividend & Yield||0.76 (1.71%)|
|Ex-Dividend Date||Jan 22, 2020|
|1y Target Est||47.13|
Pentair plc, a global water treatment company, and the Pentair Foundation announce their twenty-first consecutive year of giving.
Despite a weak manufacturing sector weighing down on the Industrial Products Sector, these five stocks are poised to beat estimates in the upcoming reporting cycle.
Pentair will report its fourth quarter and full year results before the opening of the New York Stock Exchange on Tuesday, January 28,
The FDA's ODAC votes in favor of Merck's (MRK) Keytruda for non-muscle invasive bladder cancer. The panel also backs Lynparza as a first-line maintenance monotherapy for pancreatic cancer.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Apogee's (APOG) Q3 performance likely to reflect benefits from solid bidding and order activities, robust backlog, and an upbeat North America commercial construction market.
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing more than 730 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of June […]